What is Form 483?
FDA Form 483 Inspectional Observations
Definition
An FDA Form 483 is the list of observations an FDA investigator hands to a company's management at the end of an inspection, setting out conditions that in the investigator's judgement may violate the Food, Drug, and Cosmetic Act. It records what was seen. It is not a final agency decision that the site is out of compliance.
Industry Context
PharmaTek links Form 483 records to company profiles and shows FDA inspection outcomes on manufacturing-site pages, so a buyer can see whether observations at a site were isolated or part of a pattern before asking the supplier for the documents.
When and why a Form 483 is issued
The form is issued under section 704(b) of the Food, Drug, and Cosmetic Act at the closing meeting of an inspection. Each observation describes a specific condition, such as an investigation that was not completed or a cleaning procedure that was not followed, and the observations are listed in order of significance. For drug manufacturers they are usually written against the GMP regulations in 21 CFR Parts 210 and 211.
An inspection that finds nothing objectionable ends without a 483. Receiving one is common: a large share of drug GMP inspections end with at least one observation, and most of those never go further.
What happens after a Form 483
The company is expected to respond in writing with corrective actions. The FDA considers a response received within 15 business days before it decides whether to take further action, so that is the working deadline. The investigator then writes an Establishment Inspection Report and the FDA classifies the inspection: No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI).
VAI means objectionable conditions were found but the agency will not act, provided the firm corrects them. OAI means regulatory action is recommended. That can be a Warning Letter, an import alert for a site outside the United States, or a hold on approval of applications that name the site.
Form 483 and Warning Letter compared
A Form 483 is written by the investigator on site and reflects one inspection team's observations. A Warning Letter is issued later by the agency, after review by compliance staff, and states that the FDA considers the firm to be in violation. Warning Letters are published on the FDA's website. Form 483s are not routinely published: a small number are posted, and others can be requested under the Freedom of Information Act, usually with redactions.
How buyers should read a supplier's 483
One 483 with a handful of observations is not a reason to disqualify a supplier. What matters is the content and the trend: whether observations concern data integrity, investigations or contamination control rather than documentation slips; whether the same observation appears in consecutive inspections; how the inspection was classified; and whether the response fixed the cause or only the example the investigator found.
Ask the supplier for the 483 and its response under a confidentiality agreement, and compare both with the public record. A supplier that shares them readily and can show closed corrective actions is giving you better evidence than one with no inspection history at all. European inspections produce a different record: deficiencies are graded critical, major or other, and a serious outcome is published as a statement of non-compliance in the EudraGMDP database.
Frequently asked questions
Is a Form 483 a violation?
No. It lists conditions an investigator believes may be violations. The FDA reaches a conclusion only after reviewing the inspection report and the company's response.
How long does a company have to respond to a Form 483?
There is no legal deadline, but the FDA commits to considering responses it receives within 15 business days before deciding on further action, so companies treat 15 business days as the deadline.
Are FDA Form 483s public?
Not routinely. The FDA posts some frequently requested 483s and publishes inspection classifications and citation data. Others can be obtained through a Freedom of Information Act request, usually redacted.
What is the difference between a Form 483 and a Warning Letter?
A 483 is the investigator's list of observations at the end of an inspection. A Warning Letter is a later, formal notice from the agency that it considers the firm in violation and expects prompt correction. A Warning Letter often follows a 483 whose response the FDA found inadequate.
Should a Form 483 disqualify a supplier?
Not on its own. Judge the seriousness of the observations, whether they repeat across inspections, how the inspection was classified and how well the supplier responded. Repeat observations and data-integrity findings deserve the most weight.